Be part of the knowledge.™

Living Rheum

Dedicated to uncovering clinical developments and treatment advancements in the field of rheumatology, Living Rheum delivers expert insights on patient management across a broad spectrum of rheumatic diseases, such as rheumatoid arthritis, lupus, scleroderma, osteoporosis, and more.

1-15 of 360

Medical News
$1.9M Initiative Supports Early-Career Lupus Research
04/03/2026
Medical News
Topline BE BOLD: Bimekizumab Reported Superior to Risankizumab for ACR50 at Wee…
03/16/2026
Medical News
FDA Approves Deucravacitinib (Sotyktu) for Adults with Active Psoriatic Arthrit…
03/16/2026
Medical News
Long-Term Safety with Bimekizumab in axSpA and PsA
03/12/2026
Medical News
RESILIENT Phase 3: Tonix Press Release Summarizes TONMYA Efficacy and Tolerabil…
03/11/2026
Medical News
UK CTA Approval Enables CHILL Phase 1/2 CAR‑Treg Trial in RA and SSc
03/09/2026
advertisement
Medical News
ALLEGORY NEJM Readout: Obinutuzumab Reports SRI‑4 and Steroid‑Sparing Benefits
03/09/2026
Medical News
CHILL Trial Launch: Quell’s QEL‑005 CAR‑Treg Enters Phase 1/2
03/04/2026
Medical News
FDA Accepts Brepocitinib NDA; Priority Review Assigned for Dermatomyositis
03/04/2026
Medical News
Phase III SIMBA: MB09 vs Prolia — Key Efficacy, PK/PD, Safety Findings
03/02/2026
Medical News
Cohort-Level SDoH, Mortality, and Life Expectancy in Rheumatoid Arthritis
03/02/2026
$early lipid and inflammatory changes after upadacitinib in biologic refractory spa$
Medical News
Early Lipid and Inflammatory Changes After Upadacitinib in Biologic‑Refractory …
02/27/2026
advertisement
Medical News
MoonLake S-OLARIS Phase 2 Topline: Sonelokimab ASAS40 81% at Week 12
02/24/2026
Medical News
Early vs Delayed Belimumab: 15‑Year Cost‑Effectiveness Findings
02/23/2026
Medical News
Human Study Links Epoxy‑Oxylipins to Reduced Inflammatory Monocytes and Pain
02/20/2026

Program Chapters

Segment Chapters

Playlist:

Recommended